Press Releases

At April’s SupplySide East trade show, Sabinsa Corp. (East Windsor, NJ) explained how its branded Coleus forskohlii extract ingredient, ForsLean, is approachi...

Sabinsa announces that it has been awarded Japanese Patent Number 6472453, US Patent Number 10085963, and Australian Patent Number 2015351423, entitled “Proce...

Sabinsa Corporation and Sami Labs founder Dr. Muhammed Majeed was lead author of a paper published on the cumulative safety data of ForsLean®, the company’s ...

Just in time for legitimate dietary supplement manufacturers to differentiate their products from the inferior spamtouted forskolin products driven by Dr. Oz an...

An intellectual property battle lasting three years and reaching the US Supreme Court has ended at last with payment to Sabinsa Corporation by Creative Compound...

Sabinsa’s International Presence Sabinsa Corporation’s protracted battle against Creative Compounds’ trade mark infringement of Sabinsa’...

Sabinsa’s International Presence The State Intellectual Property Office of the People’s Republic of China has granted Sabinsa a patent entitled: ...

Sabinsa Corporation has received Product Information (PI) numbers for ForsLean® 10% and 20% from Australia’s TGA (Therapeutic Goods Administration), a divisi...

Sabinsa’s International Presence Sabinsa Corporation has achieved a significant victory in protecting its intellectual property investment in ForsLean® w...

Sabinsa has been granted a patent in South Africa and Singapore as part of its PCT application on “Process of preparing water soluble diterpenes and their app...